Since it was founded, the company has been devoted to created a professional platform for international pharmaceutical cooperation, and provide effective method for cooperation with foreign partners. Till now, the companies has successfully licensed in and imported APIs and finished formulations from different countries, and has established stable cooperation relationship with partners from Italy, Korean, India, Germany, Spain and Austria.
Bocimed, with advanced facilities and strong R&D ability, is highly interested in collaborative opportunities including out-licensing, co-development, co-promotion, and co-marketing with research institutes and pharmaceutical companies domestically and internationally. The scope Bocimed is willing to cooperate includes but not limited to API and intermediates development, finished formulation development, patent and technology authorization, clinical cooperation, international registration and marketing, and pharmaceutical agent. The partnering strategy is as follows:
A) Understand Bocimed's capability & products including technical packages
B) Understand partner's needs
C) Agree on mutual interest
D) Establish a specific collaboration model
LiTai, the wholly owned subsidiary of Bocimed, provides technical service to domestic and foreign pharmaceutical companies. Company R & D department is located in the Zhangjiang High-Tech Park with strong R & D atmosphere. The laboratory covers an area of 3000 square meters, with more than 120 R & D personnel. The center has department of project management, department of drug synthesis, department of drug analysis, department of drug preparation, department of registration, department of drug intelligence information.